Mockingbird Pharma, a US based SJE Group investment, has received Quality and Security (QAS) accreditation by the National Coalition for Drug Quality & Security (NCDQS).
Mockingbird Pharma becomes just the second facility nationally to meet the accreditation program’s stringent approval criteria. The term of the accreditation is set for three years and applies to its distribution facility located in Garland, Texas.
NCDQS guidelines state that facilities receiving accreditation are verified to have proper licensing, appropriately source, handle and secure prescription products to protect product quality and integrity, authenticate vendors and customers, and comply to state and federal regulations including reporting requirements.
The accreditation process specifically included an in-depth analysis of Mockingbird Pharma’s standard operating procedures across a wide range of business functions, from employee relations to product authentication and the company’s protocol for reporting illegitimate product, as well as a thorough site inspection of its distribution facility to confirm security, storage conditions, operations and adherence to the submitted policies and procedures.
The SJE Group congratulates Clayton Salch, CEO Mockingbird Health, and the rest of the team.
About Mockingbird Pharma Mockingbird Pharma is a service-oriented wholesaler that distributes generic drugs to independent pharmacies. It offers access to an expanding product portfolio with attractive pricing and terms. Mockingbird is able to service customers in 47 states and maintains a distribution center in Garland, Texas.